Dashboard
Manage Tickers

NEPHNEPHROS INC

Nasdaq nephros.com


$ 1.92 $ -0.02 (-1.27 %)    

Wednesday, 14-Aug-2024 15:35:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.37 $ -0.93 (-0.19 %)
DIA $ 408.56 $ -0.55 (-0.13 %)
SPY $ 558.89 $ -0.27 (-0.05 %)
TLT $ 98.38 $ 0.08 (0.08 %)
GLD $ 233.45 $ -0.27 (-0.12 %)
$ 1.82
$ 1.90 x 100
-- x --
-- - --
$ 1.35 - $ 4.04
16,957
na
19.13M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-15-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-15-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-03-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-20-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
36 11-10-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-15-2015 03-31-2015 10-Q
39 04-15-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nephros-q2-eps-003-misses-001-estimate-sales-325m-miss-386m-estimate
Nephros Q2 EPS $(0.03) Misses $(0.01) Esti...
08/08/2024 20:33:56

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by ...

gee-group-and-2-other-stocks-under-3-insiders-are-buying
GEE Group And 2 Other Stocks Under $3 Insi...
05/31/2024 11:28:00

benchmark-reiterates-speculative-buy-on-nephros-maintains-5-price-target
Benchmark Reiterates Speculative Buy on Ne...
05/15/2024 11:56:15

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:NEPH) with a Speculative Buy and maintains $5 price target.

nephros-files-for-mixed-shelf-of-up-to-50m
Nephros Files For Mixed Shelf Of Up To $50M
05/10/2024 20:31:43

-SEC Filing

nephros-q1-2024-gaap-eps-002-beats-004-estimate-sales-3522m-miss-3734m-estimate
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0...
05/09/2024 21:44:19

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50...

benchmark-upgrades-nephros-to-speculative-buy-announces-5-price-target
Benchmark Upgrades Nephros to Speculative ...
03/08/2024 18:46:43

Benchmark analyst Robert Wasserman upgrades Nephros (NASDAQ:NEPH) from Hold to Speculative Buy and announces $5 price target.

nephros-q4-earnings-insights
Nephros: Q4 Earnings Insights
03/07/2024 21:45:17

nephros-q4-2023-gaap-eps-0060-misses-0030-estimate-sales-3300m-miss-3813m-estimate
Nephros Q4 2023 GAAP EPS $(0.060) Misses $...
03/07/2024 21:42:25

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) b...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

earnings-outlook-for-nephros
Earnings Outlook For Nephros
03/06/2024 18:02:29

11-consumer-discretionary-stocks-moving-in-mondays-intraday-session
11 Consumer Discretionary Stocks Moving In...
02/26/2024 17:31:12

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
12/26/2023 17:31:15

why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Despegar.com Shares Are Trading Higher...
12/13/2023 18:40:34

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
12/12/2023 17:31:17

insiders-buying-delcath-systems-and-3-other-penny-stocks
Insiders Buying Delcath Systems And 3 Othe...
12/12/2023 13:21:28

The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confi...

nephros-q3-earnings-insights
Nephros: Q3 Earnings Insights
11/08/2023 21:50:23

nephros-q3-eps-002-beats-006-estimate-sales-374m-beat-335m-estimate
Nephros Q3 EPS $(0.02) Beats $(0.06) Estim...
11/08/2023 21:49:16

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.06) by 66...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

nephros-names-judy-krandel-as-cfo-effective-today
Nephros Names Judy Krandel As CFO, Effecti...
11/01/2023 11:36:20

12-consumer-discretionary-stocks-moving-in-tuesdays-intraday-session
12 Consumer Discretionary Stocks Moving In...
09/26/2023 17:31:08

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION